Author/Authors :
Aly, Lobna A Departments of Oral and Maxillofacial Surgery - Faculty of Dentistry - Future University - New Cairo, Egypt , El- Menoufy, Hala Department of Periodontology - Oral Medicine and Oral Diagnosis - Faculty of Dentistry - Misr University for Science and Technology - Cairo, Egypt , Sadeq, Hesham S Department of Periodontology - Oral Medicine and Oral Diagnosis - Faculty of Dentistry, Egypt , Ragae, Alyaa Faculty of Dentistry - Future University - New Cairo, Egypt , Sabry, Dina Department of Medical Biochemistry - Faculty of Medicine - Cairo University - Giza, Egypt
Abstract :
Background: Bone marrow mesenchymal stem cells (BMSCs) are the key to regenerative wound
healing. MSCs have spatial memory and respond to local environment. The goal of this study was
to evaluate the use of systemic and intralesional transplantation of BMSCs for regeneration of oral
mucosa in an in vivo dog model.
Materials and Methods: Transplantation of undifferentiated green fluorescent protein (GFP)-
labeled autologous BMSCs systemically, submucosally or vehicle (saline) was injected around the
chemically induced oral ulcer in each group of 18 adult dogs. The healing process of the ulcer was
monitored clinically and histopathologically. Gene expression of vascular endothelial growth factor
(VEGF) and collagen genes was detected in biopsies from all ulcers. One way ANOVA was used
to compare between means of the three groups. Results were considered significant at P < 0.05.
Results: Flow cytometric analysis of the MSCs at the passage 3 showed that these cells were
negative for CD45 (2.39%). They expressed high levels of CD29 (98.34%). Frozen fluorescence
microscopy of sections of the cell-treated oral tissue of all groups indicated that the GFP-transduced
implanted cells were integrated within the transplanted tissues. The treatment resulted in dramatic
wound edge activation and resurfacing of oral mucosa wound.
Conclusion: Our results revealed that BMSCs may be labeled with (GFP), in order to know the distribution
of these cells after administration, and suggest that intralesional administration is an appropriate procedure
to achieve acceptable regeneration of the previously injured oral mucosa more than systemic route.